These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24574299)

  • 1. Use of mycobacteriophage quantitative PCR on MGIT broths for a rapid tuberculosis antibiogram.
    Foongladda S; Klayut W; Chinli R; Pholwat S; Houpt ER
    J Clin Microbiol; 2014 May; 52(5):1523-8. PubMed ID: 24574299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis.
    Pholwat S; Ehdaie B; Foongladda S; Kelly K; Houpt E
    J Clin Microbiol; 2012 Mar; 50(3):754-61. PubMed ID: 22170929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico.
    Banaiee N; Bobadilla-Del-Valle M; Bardarov S; Riska PF; Small PM; Ponce-De-Leon A; Jacobs WR; Hatfull GF; Sifuentes-Osornio J
    J Clin Microbiol; 2001 Nov; 39(11):3883-8. PubMed ID: 11682502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.
    Banaiee N; Bobadilla-Del-Valle M; Riska PF; Bardarov S; Small PM; Ponce-de-Leon A; Jacobs WR; Hatfull GF; Sifuentes-Osornio J
    J Med Microbiol; 2003 Jul; 52(Pt 7):557-561. PubMed ID: 12808076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoluciferase Reporter Mycobacteriophage for Sensitive and Rapid Detection of Mycobacterium tuberculosis Drug Susceptibility.
    Jain P; Garing S; Verma D; Saranathan R; Clute-Reinig N; Gadwa J; Peterson C; Hermansky G; Astashkina Fernandez A; Asare E; Weisbrod TR; Spencer E; Mulholland CV; Berney M; Bell D; Nichols KP; Le Ny AM; Ordway D; Jacobs WR; Somoskovi A; Minch KJ
    J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32900827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
    Şimşek H; Tarhan G; Cesur S
    Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960.
    Adami AG; Gallo JF; Pinhata JM; Martins MC; Giampaglia CM; de Oliveira RS
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):108-111. PubMed ID: 27889251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa.
    Banaiee N; January V; Barthus C; Lambrick M; Roditi D; Behr MA; Jacobs WR; Steyn LM
    Tuberculosis (Edinb); 2008 Jan; 88(1):64-8. PubMed ID: 17980664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
    Sanogo M; Kone B; Diarra B; Maiga M; Baya B; Somboro AM; Sarro YS; Togo ACG; Dembele BPP; Goita D; Kone A; M'Baye O; Coulibaly N; Diabate S; Traore B; Diallo MH; Coulibaly YI; Saleeb P; Belson M; Orsega S; Siddiqui S; Polis MA; Dao S; Murphy RL; Diallo S
    Clin Microbiol Infect; 2017 Jun; 23(6):408.e1-408.e6. PubMed ID: 28110049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.
    Makamure B; Mhaka J; Makumbirofa S; Mutetwa R; Mupfumi L; Mason P; Metcalfe JZ
    PLoS One; 2013; 8(2):e55872. PubMed ID: 23409072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The manual mycobacteria growth indicator tube and the nitrate reductase assay for the rapid detection of rifampicin resistance of M. Tuberculosis in low resource settings.
    Adikaram CP; Perera J; Wijesundera SS
    BMC Infect Dis; 2012 Nov; 12():326. PubMed ID: 23186045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for
    Sivaramakrishnan G; Subramanyam B; Kumar MP; Golla R; Tripathy SP; Mondal R
    Int J Mycobacteriol; 2019; 8(4):329-332. PubMed ID: 31793501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs.
    Gallo JF; Pinhata JMW; Saraceni CP; de Oliveira RS
    J Microbiol Methods; 2017 Aug; 139():168-171. PubMed ID: 28601653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study.
    Siddiqi S; Ahmed A; Asif S; Behera D; Javaid M; Jani J; Jyoti A; Mahatre R; Mahto D; Richter E; Rodrigues C; Visalakshi P; Rüsch-Gerdes S
    J Clin Microbiol; 2012 Feb; 50(2):435-40. PubMed ID: 22162558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
    Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
    PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].
    Çoban AY; Taştekin B; Uzun M; Kalaycı F; Ceyhan İ; Biçmen C; Albay A; Sığ AK; Özkütük N; Sürücüoğlu S; Özkütük A; Esen N; Albayrak N; Aslantürk A; Sarıbaş Z; Alp A
    Mikrobiyol Bul; 2016 Jan; 50(1):140-6. PubMed ID: 27058338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.